Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 10-K Report Annual Report
  2. 8-K/A Event Bylaws or fiscal year change
  3. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Regulation FD disclosure
  8. 8-K Event Delisting notice
  9. 8-K Event Regulation FD disclosure
  10. 8-K Event Executive or director change
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Shareholder vote results
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Other events
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Director nominations
  18. 8-K Event Regulation FD disclosure
  19. 8-K Event Executive or director change
  20. 10-K Report Annual Report

Page 3 of 11 · 203 filings